VivoSim Labs (VIVS) Total Current Liabilities (2011 - 2026)
VivoSim Labs (VIVS) posted Total Current Liabilities of $1.9 million for Q2 2026, down 31.78% on a QoQ basis from $2.8 million in Q1 2026, and down 11.3% year-over-year from $2.1 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Total Current Liabilities (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Total Current Liabilities for 16 years, with the latest figure at $1.9 million in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 11.3% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a 11.3% decrease from a year earlier, with the FY2026 full-year figure at $2.8 million, down 25.47% from the prior year.
- Total Current Liabilities was $1.9 million for Q2 2026 at VivoSim Labs, down from $2.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $3.7 million in Q1 2025, with the low at $1.3 million in Q2 2022.
- Average Total Current Liabilities over 5 years is $2.2 million, with a median of $2.0 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities surged 165.44% in 2023, then plunged 49.33% in 2024.
- Over 5 years, Total Current Liabilities stood at $1.4 million in 2022, then gained by 23.55% to $1.7 million in 2023, then jumped by 72.76% to $2.9 million in 2024, then declined by 14.88% to $2.5 million in 2025, then fell by 24.0% to $1.9 million in 2026.
- The last three Total Current Liabilities figures came in at $1.9 million (Q2 2026), $2.8 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 8.82 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.44 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.93 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.13 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 963.70 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 363.19 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 72.74 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 18.73 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 4.76 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.90 Mn |
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 3.74 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 3.67 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 2.01 Mn |
| Sep 30, 2021 | 1.68 Mn |